Today

Agents

Chat

Arena

Discover

More

App

SELLAS Life Sciences Q2 Net Income USD -9.605 Million - SLS News | Rallies

SELLAS Life Sciences Q2 Net Income USD -9.605 Million

SLS•2026-08-11

Q2 results

Aug. 11 (Reuters) - SELLAS Life Sciences Q2 operating income was USD -10.629 million.

Q2 basic EPS: USD -0.05
Q2 operating expenses: USD 10.629 million

Related News

Chairman & CEO David Golub lepas 1.676.387 saham Golub Capital BDC senilai $21,89 juta

GBDC•2026-08-11

Zapata Quantum Files Prospectus For 56.8 Million Shares Of Common Stock For Resale By Selling Stockholders

ZPTA•2026-08-11

Brief-NRC Health - On Aug 7, Shane Harrison, CFO Of NRC Health, Tenders Resignation

NRC•2026-08-11

Regal Rexnord SVP, Corporate Controller and CAO Alexander P. Scarpelli melepas 170 saham senilai USD 29.960,46

RRX•2026-08-11

Aura Biosciences May Offer Securities Up To $500 Million Aggregate

AURA•2026-08-11